Literature DB >> 2947749

The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study.

D D Savage, R J Garrison, W B Kannel, D Levy, S J Anderson, J Stokes, M Feinleib, W P Castelli.   

Abstract

To assess the prevalence, characteristics, and correlates of echocardiographically determined left ventricular hypertrophy (echo LVH) in a free-living population, 510 men and 855 women from the original Framingham cohort (age 59 to 90 years) were studied by M-mode echocardiography. Offspring and offspring spouses (1718 men and 1892 women; age 17 to 75 years) were similarly studied. The severity of echo LVH, as reflected by left ventricular mass indexed to body surface area, ranged from 101 g/m2 (women) and 132 g/m2 (men) to more than 400 g/m2. The prevalence of electrocardiographically assessed LVH increased proportionately with increased echocardiographic left ventricular mass. Women with echocardiographic left ventricular mass indexes exceeding 200 g/m2 were three to four times more likely to have electrocardiographic LVH than men with similar elevations of echocardiographic left ventricular mass index. The prevalence of echo LVH ranged from 6.6% in the younger (offspring study) women to 33% in the older (original cohort) women (8.6% and 23.7%, respectively, for men) and included a spectrum of forms--eccentric-dilated, eccentric-nondilated, concentric, and disproportionate septal thickness--which varied in prevalence in the various age-sex groups. Each of these forms of echo LVH was associated with higher systolic blood pressures at the time of echocardiographic examination and over the previous 30 years when compared with blood pressures of Framingham subjects without echo LVH.

Entities:  

Mesh:

Year:  1987        PMID: 2947749

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  52 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

2.  Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome.

Authors:  Federico Guerra; Lucia Mancinelli; Alessia Buglioni; Valentina Pierini; Alessandro Rappelli; Paolo Dessì-Fulgheri; Riccardo Sarzani
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-12-01

3.  Cardiothoracic ratio within the "normal" range independently predicts mortality in patients undergoing coronary angiography.

Authors:  M Justin S Zaman; Julie Sanders; Angela M Crook; Gene Feder; Martin Shipley; Adam Timmis; Harry Hemingway
Journal:  Heart       Date:  2006-12-12       Impact factor: 5.994

Review 4.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

5.  Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis.

Authors:  Kevin G Friedman; Doff B McElhinney; Steven D Colan; Diego Porras; Andrew J Powell; James E Lock; David W Brown
Journal:  Circ Cardiovasc Interv       Date:  2012-06-26       Impact factor: 6.546

Review 6.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

7.  Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy.

Authors:  Marie-Eve Gendron; Eric Thorin; Louis P Perrault
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

8.  The association between left ventricular hypertrophy and biomarkers in patients on continuous ambulatory peritoneal dialysis.

Authors:  Sang-Ho Park; Se-Whan Lee; Seung-Jin Lee; Won-Yong Shin; Dong-Kyu Jin; Hyo-Wook Gil; Jong-Oh Yang; Eun-Young Lee; Sae-Yong Hong
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

9.  Increased cardiovascular stiffness and impaired age-related functional status.

Authors:  Mousumi M Andersen; Stephen B Kritchevsky; Timothy M Morgan; Don G Hire; Sujethra Vasu; Tina E Brinkley; Dalane W Kitzman; Craig A Hamilton; Sandra Soots; William G Hundley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06-24       Impact factor: 6.053

10.  Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).

Authors:  Herman A Taylor; Alan D Penman; Hui Han; Abiola Dele-Michael; Thomas N Skelton; Ervin R Fox; Emelia J Benjamin; Donna K Arnett; Thomas H Mosley
Journal:  Am J Cardiol       Date:  2007-04-10       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.